Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak

Active
75F40126Q00327Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract seeks sequencing services for the Bundibugyo virus disease (BDBV) during the 2026 outbreak, with solicitation number 75F40126Q00327 issued by the FDA Office of Acquisition and Grant Services under the U.S. Department of Health and Human Services. The opportunity was posted on August 4, 2026, with responses due by August 10, 2026, at 4:00 PM Eastern Time, and no set-aside is applicable, meaning it is open to all eligible vendors. The North American Industry Classification System code is 541714, indicating it falls under research and development in the biological sciences. Performance location details are not specified, but the contracting office is based in Rockville, Maryland, 20852, and the primary point of contact is Ryan Alexander, reachable via email at ryan.alexander@fda.hhs.gov. The solicitation is accessible through the SAM.gov platform for further details and submission.

General Info

FDA seeks BDBV sequencing services for 2026 outbreak via SAM.gov by August 10, 2026, open to all eligible entities.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(3)

Pricing Sheet for Sequencing Bundibugyo Virus Disease Project

XLSX•pricing-sheet

Solicitation 75F40126Q00327 - Sequencing Bundibugyo Virus Disease

PDF•rfp

SOW for Sequencing Bundibugyo Virus Disease Outbreak 2026

DOCX•sow

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA
Contacts
Ryan Alexander
contact@example.gov

Full Description

Show more

Title: Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreak


Questions: 08/07/26


Responses Due: 08/10/26



Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Evaluation of a Lead NNMT Inhibitor in Humanized M
Solicitation # 75N98026Q00941
The National Institutes of Health, Office of the Director, intends to award a non-competitive, firm-fixed price contract to GemPharmatech LLC for the evaluation of a lead NNMT inhibitor using a humanized nicotinamide N-methyltransferase mouse model, a model uniquely developed and maintained by GemPharmatech under prior NIH funding. This acquisition is conducted under streamlined commercial item procedures and is not expected to exceed the simplified acquisition threshold, with authority derived from FAR 12.603 and 41 U.S.C. 1901, and justified under the sole source exception for unique capabilities, as GemPharmatech is the only entity with the cryopreserved sperm and breeding resources necessary to regenerate the required mouse colony essential for generating scientifically relevant efficacy data due to the inhibitor's species-specific activity. The solicitation number is 75N98026Q00941, issued as a combined synopsis and solicitation without competitive procedures, and responses are due by August 19, 2026. The work falls under NAICS code 541714 for Research and Development in Biotechnology with a small business size standard of 1,000 employees, and this requirement is not set aside for small business. The contract will be managed by the NIH Office of Acquisitions based in Bethesda, Maryland, with the primary point of contact being Johnstona C. Johnston, reachable via email. All provisions and clauses follow those in effect through the Federal Acquisition Circular dated August 4, 2026, and the notice serves as the complete and only solicitation document; no additional written solicitation will be issued. The performance location is not specified beyond the federal agency's administrative details.
National Institutes Of Health Olao

POSTED

1 day ago

DEADLINE

in 14 days
View Details
NAICS: 541714
New
Federal
Yeast Two-Hybrid (Y2H) Screening Service
Solicitation # 1232SA26Q1181
The U.S. Department of Agriculture’s Agricultural Research Service is soliciting quotations for Yeast Two-Hybrid (Y2H) Screening Services under solicitation number 1232SA26Q1181, issued as a combined synopsis and solicitation in accordance with FAR Part 12 for commercial items. This acquisition is exclusively reserved for small business concerns, with the North American Industry Classification System code 541714 for Research and Development in Biotechnology and a size standard of 1,000 employees, making it a total small business set-aside. Only responsible small business sources may submit quotations, which will be evaluated without the issuance of a separate written solicitation. The quote submission deadline is August 28, 2026, at 22:00 Eastern Time, with the solicitation publicly posted on August 4, 2026, and responses due to the USDA ARS office located in Beltsville, Maryland. The performance of the Y2H screening services is required to take place in Ithaca, New York, 14853. The primary point of contact for inquiries is Kerrie Hodges, reachable via email at kerrie.hodges@usda.gov. The contract is being procured by the USDA ARS Affiliated Programs and Development office and is intended to support research activities for the Robert W. Holley Center for Agriculture and Health. Interested parties must submit their quotations through the SAM.gov platform using the provided UI link, and all responses must comply with the commercial item procurement procedures outlined in FAR Part 12. No further documentation or separate solicitation documents will be issued.
USDA Ars Afm Apd

POSTED

1 day ago

DEADLINE

in 23 days
View Details
NAICS: 541714
New
Federal
Genotyping
Solicitation # 1232SA26Q0963
This solicitation, numbered 1232SA26Q0963, is a combined synopsis and request for quotation for genotyping services under FAR Part 12, with no separate written solicitation to follow. It is a total small business set-aside, restricted exclusively to small businesses as defined by the NAICS code 541714 and the 1,000-employee size standard. All responsible small business sources are encouraged to submit quotations, which will be evaluated based on criteria outlined in Attachment 1, which includes the full terms, conditions, and evaluation parameters. The solicitation incorporates provisions and clauses by reference, accessible electronically at www.acquisition.gov. The contract is issued by the USDA ARS AFM APD, with the office located in Beltsville, Maryland, and performance required in Maricopa, Arizona, ZIP 85138. Responses are due by August 12, 2026, at 7:00 p.m. Eastern Time, and the opportunity was posted on August 4, 2026. The primary point of contact for inquiries is Frank Palmer, reachable via email at frank.palmer@usda.gov, and additional details can be viewed on the SAM.gov website at the provided UI link.
USDA Ars Afm Apd

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 541714
New
Federal
AN11--36C25226R0084 - TBI research with Arraystar Inc FY2026
Solicitation # 36C25226R0084
The Department of Veterans Affairs is seeking information from potential vendors to support a sole source procurement for Methylated and hydroxymethylated DNA immunoprecipitation sequencing (MeDIP-seq and hMeDIP-seq) services under solicitation number 36C25226R0084. This effort is part of a TBI research project at the William S Middleton VA Medical Center in Madison, Wisconsin, aimed at understanding epigenetic changes—specifically the roles of 5-methylcytosine and 5-hydroxymethylcytosine—in secondary brain damage following trauma. The contract requires comprehensive sequencing and data analysis of mouse brain tissue samples from adult and aged males and females to identify sex- and age-specific patterns. The work must be performed using the same tissue samples for both MeDIP and hMeDIP to minimize variability and ensure reliable comparative results. The vendor will deliver raw sequencing data in Fastq format, quality control reports, analytical summaries, and final project reports in Excel, PDF, and PNG formats within 56 to 70 days of contract start. Submission of capability statements is required by August 10, 2026, via email only, with no phone inquiries accepted, and must include customer references and technical proof of capability. This is not a solicitation or request for proposals but a sources sought notice to justify a sole source award under 41 U.S.C. 1901, as the VA believes only one vendor can meet the highly specialized scientific requirements. The principal investigator will evaluate all submissions due to the technical nature of the research and will determine vendor suitability. The contract, if awarded, will be a firm fixed price agreement for one year, with no option periods, running from August 10, 2026, to August 9, 2027. All deliverables must be transmitted via USB drive, as the research laboratory operates in an affiliate space disconnected from the VA network. Responses must be emailed to Tiarrah Turner at the VA Great Lakes Acquisition Center in Milwaukee, Wisconsin, with attachments not exceeding 8 MB each. The government retains full discretion to proceed with sole source negotiation regardless of responses received. No federal funds are allocated under the Recovery Act for this procurement.
252-NETWORK Contract Office 12 (36C252)

POSTED

2 days ago

DEADLINE

in 5 days
View Details
NAICS: 541714
New
Grant
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Solicitation # RFA-CK-26-035
This funding opportunity aims to strengthen the detection, prevention, and management of infectious diseases among international travelers by establishing a robust research network focused on real-world surveillance and clinical insights. The initiative seeks to improve the speed and accuracy of outbreak detection, enhance understanding of disease progression, refine diagnostic and treatment approaches, and optimize genomic surveillance—all with the goal of advancing U.S. global health security. Research must directly address public health challenges linked to travel-associated infections, with an emphasis on generating actionable data that informs guidelines and improves patient care outcomes. The program includes two distinct but complementary components: a clinic-based sentinel network that collects clinical and epidemiological data from healthcare settings serving travelers, and a sentinel detection system embedded within international transportation hubs such as airports and seaports to capture early signals of emerging threats. Applicants may submit proposals for one or both components, but if a single applicant receives top scores for both, funding will be awarded only for Component B, ensuring resources are directed toward the most critical point of pathogen introduction. Applications must be submitted by November 5, 2026, through the CDC’s solicitation RFA-CK-26-035, with direct inquiries to the designated point of contact at the Centers for Disease Control and Prevention.
Centers For Disease Control And Prevention

POSTED

2 days ago

DEADLINE

in 3 months
View Details
NAICS: 541714
New
Federal
Presolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Solicitation # 75A50126R00001_RFP_PreSolNotice_NPIVS-2027
The U.S. Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is seeking qualified contractors to support the ongoing Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. Contractors must be capable of furnishing all necessary services, personnel, equipment, materials, and U.S.-based facilities to produce vaccines, antigens, and adjuvants for pandemic influenza and other viruses with pandemic potential. To be eligible, offerors must either hold an active U.S. influenza vaccine license from the FDA or have submitted a Biologics License Application for a seasonal or pandemic influenza vaccine. The program demands the generation and submission of comprehensive regulatory data—including analytical, nonclinical, clinical, and chemistry, manufacturing, and controls (CMC) information—to the FDA to enable rapid decision-making and maintain manufacturing readiness during interpandemic periods. The anticipated contract is an indefinite delivery, indefinite quantity (IDIQ) vehicle with a base performance period of 60 months and the potential to extend up to 120 months if all option periods are exercised, combining both cost-reimbursement and firm-fixed-price task orders. Performance is expected to occur primarily within the United States, with the place of performance designated as Washington, D.C., and the contracting office located at 400 7th Street SW. Proposals must be submitted electronically via SAM.gov by the deadline of August 15, 2026, and are subject to evaluation based on mandatory qualification requirements, with full evaluation factors and source selection criteria expected to be detailed in the forthcoming Request for Proposals. The solicitation number is 75A50126R00001, and the NAICS code is 541714 for research and development in biotechnology. The primary point of contact for inquiries is Laura Saddison, BARDA Contracting Officer, reachable at Laura.Saddison@hhs.gov. No set-aside is planned, and full and open competition is anticipated. While packaging, marking, inspection procedures, and specific invoicing methods are not defined in this presolicitation, contractors should prepare to comply with FDA regulatory standards and anticipate the use of federal systems such as WAWF for payment processing. No contracting officer’s representative or technical representative has been designated yet, and all certifications and representations will be required upon formal proposal submission.
Barda - Aspr / Daappo / Barda Dcma

POSTED

5 days ago

DEADLINE

in 10 days
View Details
NAICS: 541714
New
Federal
Convergence Special Notice
Solicitation # DARPA-SN-26-108
The Convergence program seeks to revolutionize environmental monitoring for defense operations by integrating synthetic biology and engineering to create advanced microbial biosensors capable of detecting chemical and pharmaceutical hazards in austere environments. Leveraging non-pathogenic microbial consortia built on well-characterized, safe host organisms like E. coli, the initiative focuses on developing modular biological systems that translate environmental inputs into standardized, detectable outputs. The program’s development follows a structured four-tiered approach, progressing from component-level design and integrated payload engineering to full system integration within a microbial chassis, ultimately aiming for a deployable platform ready for U.S. and international regulatory certification. This systematic progression ensures that each layer of functionality is rigorously validated before scaling to operational readiness. To enable safe, responsible, and globally viable deployment, the program includes a dedicated ecosystem of testing and collaboration. Performance and safety validation will first occur within the United States before exploring international adoption, with two specialized working groups guiding the process: one focused on navigating socio-political landscapes and local environmental regulations, and another managing cooperative use cases and deployment protocols with global allies. Administered by DARPA, the solicitation under number DARPA-SN-26-108 invites multidisciplinary teams in synthetic biology, environmental science, and engineering to contribute to this initiative, with responses due by August 6, 2026. The program is headquartered in Arlington, Virginia, and is led by Mark Salvador, with the goal of delivering a scalable, secure, and globally interoperable biosensor platform for the protection of military personnel.
Defense Advanced Research Projects Agcy

POSTED

6 days ago

DEADLINE

in 7 days
View Details
NAICS: 541714
New
Federal
Multiscale Reasoning For Human Physiology RFI
Solicitation # DARPA-SN-26-100
The Defense Advanced Research Projects Agency’s Biological Technologies Office is seeking input on cutting-edge technologies that enable multiscale reasoning across human physiology through this Request for Information, identified as DARPA-SN-26-100. The focus is on emerging tools including artificial intelligence systems, foundation models, computational frameworks, and datasets capable of integrating biological, physiological, and clinical data across multiple scales—from molecular and cellular levels to organ systems and whole-body responses. The goal is to advance the ability to model, predict, and interpret complex human physiological behavior using AI and data-driven approaches, with interest in non-traditional performers and innovative solutions from industry, academia, government labs, and healthcare organizations. Responses are due by August 10, 2026, and the solicitation falls under NAICS code 541714 for research and development in the physical, engineering, and life sciences. All submissions should be directed to Dr. Roozbeh Jafari, Program Manager at DARPA/BTO, via bioreasoning@darpa.mil. The office is located in Arlington, Virginia, and while no specific place of performance is defined, selected technologies may be developed and evaluated through future DARPA programs. This RFI does not constitute a solicitation for proposals or obligations but aims to inform upcoming funding opportunities in the field of physiological modeling and AI-driven biological insight.
Defense Advanced Research Projects Agcy

POSTED

6 days ago

DEADLINE

in 15 days
View Details
NAICS: 541714
Federal
Trusted Partner Program Coming Soon
Solicitation # W911NF26RA009
The U.S. Army, through the Army Research Office and the Office of Contracting at Research Triangle Park, North Carolina, is issuing a presolicitation for the Trusted Partner Program, a multiple-award IDIQ contract aimed at establishing a cadre of trusted academic partners—including institutions of higher education and their affiliated entities—to conduct rapid, sensitive basic and applied scientific research in support of national defense priorities. The solicitation, numbered W911NF26RA009, targets research in Scaled Directed Energy and Scaled Hypersonics, requiring multidisciplinary expertise across physics, electronics, chemistry, materials science, information sciences, and biology, with an emphasis on integrating these fields to address complex Army needs. The base performance period is five years, beginning September 2026, with an optional five-year extension, bringing the total potential contract value to $400 million, with individual task orders to be issued under cost-plus-fixed-fee or firm-fixed-price arrangements. Offerors must submit proposals in five separate volumes, each as a searchable PDF, along with a supplemental unclassified video pitch between three and seven minutes in length, formatted in MPEG-4 at 1080p resolution. Proposals are due by 4:00 PM Eastern Time on July 15, 2026, and must be emailed to the designated point of contact. Evaluation will be conducted based on five factors, ranked in order of importance: Technical (most important), Management, Past Performance, Small Business, and Cost & Business Structure (least important non-cost factor). No numerical weights are assigned, and the award will be made using a trade-off process emphasizing superior technical merit over price, with the expectation that all non-cost factors combined carry significantly greater weight than cost. The Technical factor includes equally weighted subfactors centered on expertise in six core disciplines and six critical interdisciplinary projects, assessed using adjectival ratings from BLUE (outstanding, low risk) to RED (unacceptable, unawardable). Compliance with regulatory requirements is strict: contractors must maintain active UEI and CAGE codes in SAM, adhere to cybersecurity maturity model certification requirements, and submit all deliverables in accordance with Department of Transportation packaging standards and marking requirements that include contract number, project title, and sensitive data classification. Travel is highly regulated, requiring prior COR approval and adherence to JTR per diem limits; OCONUS travel necessitates SPOT registration and a Letter of Authorization. Organizational conflicts of interest will be rigorously assessed, and all
W6QK Acc-Apg Durham

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541714
Federal
Multimodal Sensor Integration and Signal Fusion EngineeringThe contract seeks integration of multiple sensing modalities into a unified platform designed for real-time pharmaceutical inspection, emphasizing synchronized signal correlation and advanced noise reduction techniques. The project requires the engineering of a robust system capable of fusing data from diverse sensor types to enhance detection accuracy, reliability, and speed in identifying product defects or anomalies during manufacturing processes. Development must ensure temporal and spatial alignment of signals, adaptive filtering for environmental and operational interference, and seamless interoperability across hardware and software components to support continuous, high-fidelity monitoring. This subcontract, under NAICS code 541714 and sponsored by the Advanced Research Projects Agency for Health within the Department of Health and Human Services, targets innovation in sensor fusion technologies with a specific focus on quality assurance in pharmaceutical production. The place of performance is designated as Washington DC with a zip code of 20005, and proposals must be submitted by August 20, 2026. The initiative aims to advance detection capabilities beyond conventional single-sensor approaches, enabling next-generation inspection systems that meet stringent regulatory standards through data-driven, real-time analytics.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

8 days ago

DEADLINE

in 15 days
View Details
NAICS: 541714
Federal
Sources Sought – RRBS Sequencing Services
Solicitation # 36C241-26-AP-4037
The Department of Veterans Affairs is seeking qualified Service-Disabled Veteran-Owned Small Businesses and Veteran-Owned Small Businesses to provide Reduced Representation Bisulfite Sequencing services for a neurodegenerative disease research program involving approximately 269 de-identified human post-mortem choroid plexus tissue samples. The scope includes comprehensive sample handling and quality control, bisulfite conversion, library preparation, Illumina paired-end sequencing generating about 30 million read pairs per sample, and downstream bioinformatics analysis such as raw data alignment, methylation calling, and genome browser track generation, with an expected turnaround time of six to eight weeks. This notice is issued for market research purposes under the Veterans First Contracting Program and is intended to evaluate potential for a set-aside under the VA Rule of Two, ensuring opportunities for SDVOSBs and VOSBs. All interested parties must submit a capability statement detailing their technical expertise, business size and status as an SDVOSB or VOSB, and facility location by 11:00 AM EST on August 12, 2026, to Chelsea Cortright at Chelsea.Cortright@va.gov with the subject line referencing ID# 36C241-26-AP-4037. The opportunity is not a solicitation or request for proposals, and no contract will be awarded directly from this notice. The effort is managed by the 241-NETWORK Contract Office 01 based in Togus, Maine, with performance occurring in Bedford, Massachusetts, under NAICS code 541714 for analytical laboratory services. Additional inquiries can be directed to Jennifer Fiore, the secondary point of contact.
241-NETWORK Contract Office 01 (36C241)

POSTED

8 days ago

DEADLINE

in 7 days
View Details
NAICS: 541714
Federal
Research service necessary to execute a NAMRU SOUTH Zika study in Panama.
Solicitation # ERP_PR_1301393620
Naval Medical Research Unit South is seeking research services to support its Virology Department’s febrile and respiratory surveillance study, specifically in support of a Zika virus study in Panama. The government has conducted market research and determined that only Fundacion Ciudad del Saber possesses the unique capability to fully meet the technical and operational requirements of the study, making the procurement eligible for a sole source award under FAR 13.106-1(b)(i). No competitive solicitation exists, and this notice serves solely as an opportunity for other potential vendors to demonstrate their capability to perform the work. Interested parties must submit a capability statement not exceeding five pages in 10-point font or larger, containing detailed management, technical, and cost information with convincing evidence of their ability to fulfill the requirement. Submissions must be sent via email as a Word or PDF attachment to genaro.m.vasquez.ln@health.mil with the subject line “ERP PR_1301393620” no later than 12:00 PM local time on August 11, 2026. Responses consisting only of questions or requests for clarification will not be accepted. The government retains full discretion to proceed with a sole source award or open a competitive process based on the submissions received. The contracting office is located in Washington, DC, and the primary point of contact is Genaro Vasquez.
Naval Medical Research Unit South

POSTED

9 days ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 811212
New
Federal
Warranty and Preventive Maintenance SupportThe contract provides warranty coverage and optional preventive maintenance services for solvent evaporation units under a subcontract arrangement, with coverage spanning one to two years. The work is specifically targeted at ensuring the continued operational reliability of these units through scheduled maintenance and repair support, with performance expected to occur in Denver. The solicitation, posted by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, is classified under NAICS code 811212, which relates to industrial and commercial equipment repair and maintenance. Responses must be submitted by August 10, 2026, with no set-asides specified for small businesses or other categories, and the contracting office has not provided a point of contact for inquiries.
Computer and Office Machine Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 611430
New
Federal
Training for FDA Laboratory PersonnelThe contract involves providing hands-on training to FDA laboratory personnel on the operation, maintenance, and safety protocols for newly installed solvent evaporation systems. The training must be delivered in person at the designated place of performance in Denver and is intended to ensure that FDA staff are fully competent and compliant with all procedural and safety requirements associated with the equipment. The work is classified under NAICS code 611430, indicating it falls under professional and technical training services. The opportunity was posted on August 4, 2026, with a response deadline of August 10, 2026, and is structured as a subcontract under the Department of Health and Human Services, specifically managed by the FDA Office of Acquisition and Grant Services. The procurement does not specify a set-aside type or additional organizational details, and the point of contact information is not provided.
Professional and Management Development Training

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 811212
New
Federal
Installation and Commissioning of Evaporation SystemsThe contract involves the on-site installation, calibration, and performance verification of two solvent evaporation units at the FDA facility in Denver, Colorado. The work requires precise technical execution to ensure the systems operate within specified parameters for regulatory compliance and operational efficiency. All activities must be completed at the designated location, with no provision for off-site preparation or remote handling. The contract is classified as a subcontract under NAICS code 811212, indicating it pertains to industrial machinery and equipment repair and maintenance services. The opportunity was posted on August 4, 2026, with a strict response deadline of August 10, 2026, at 6:00 PM, leaving a narrow window for interested parties to submit proposals. The procuring entity is the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, emphasizing the critical nature of the equipment for federal regulatory functions. There is no set-aside designation provided, meaning all eligible subcontractors may compete for this award.
Computer and Office Machine Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 333318
New
Federal
Supply of Solvent Evaporation Systems (Standard Model)The contract is for the procurement and delivery of one standard solvent evaporation system intended for routine sample preparation workflows, classified under NAICS code 333318, which corresponds to laboratory machinery and equipment manufacturing. This is a subcontract issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with performance required in Denver. The solicitation was posted on August 4, 2026, and responses are due by 6:00 PM ET on August 10, 2026. The system must meet standard specifications for reliable, repeatable solvent removal in laboratory environments, supporting consistent analytical sample preparation. No set-aside designation is specified, indicating the opportunity is open to all eligible contractors without preference for small businesses or other categories. The contract does not include detailed contact information, and all submission and evaluation processes must be handled through the provided SAM.gov portal link.
Other Commercial and Service Industry Machinery Manufacturing

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 333318
New
Federal
Supply of Solvent Evaporation Systems (High-Throughput Model)The contract is for the procurement and delivery of a high-throughput solvent evaporation system designed specifically for HPLC/LC-MS/MS sample preparation, intended to replace aging and obsolete equipment. The system must meet stringent performance requirements to ensure accurate, efficient, and reliable sample processing in a high-volume analytical environment. The solicitation is issued under the NAICS code 333318, indicating it relates to laboratory machinery and equipment manufacturing, and is structured as a subcontract under the Department of Health and Human Services’ FDA Office of Acquisition and Grant Services. The place of performance is specified as Denver, with a clear deadline for responses set for August 10, 2026, at 6:00 PM. The posting date indicates the opportunity was made available on August 4, 2026, granting potential vendors a brief six-day window to submit proposals. No set-aside provisions or additional organizational details are provided, implying the contract is open to qualified suppliers without specific socioeconomic restrictions. The procurement aims to modernize laboratory capabilities critical to the FDA’s analytical operations.
Other Commercial and Service Industry Machinery Manufacturing

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 493190
New
Federal
Packaging, Certification, and Logistics for Analytical StandardsThe contract requires comprehensive final packaging, cold chain logistics, certificate of analysis (COA) management, and secure shipment of analytical reference standards to the FDA Denver Laboratory, ensuring all materials maintain their integrity through transit via dry ice or cold packs. The work must adhere to strict temperature controls and documentation standards to meet regulatory requirements, with all packaging and labeling protocols designed to support the stability and traceability of the standards during transport. This subcontract, issued under the NAICS code 493190 by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, is targeted for performance at the Denver 80225 location. The solicitation was posted on August 4, 2026, with responses due by August 7, 2026, and no set-aside type has been designated. The scope demands precision in handling, certification, and delivery, with full accountability throughout the process to ensure compliance with federal laboratory standards for analytical reference materials.
Other Warehousing and Storage

POSTED

1 day ago

DEADLINE

in 2 days
View Details
NAICS: 325412
New
Federal
Custom Multi-Component Veterinary Drug Reference Standards (Amphenicols, Avermectins, Nitroimidazoles, Quinolones, Fluoroquinolones)The contract calls for the production of ISO 17034-certified reference standards targeting multiple veterinary drug classes, including chloramphenicol, ivermectin, metronidazole, and enrofloxacin, encompassing amphenicols, avermectins, nitroimidazoles, and fluoroquinolones. Each class will be delivered in two certified lots, designated as ICV and CCV, with each lot consisting of five 1mL ampules, ensuring consistent, traceable, and analytically validated materials for regulatory and laboratory use. Full analytical documentation must accompany each batch, confirming identity, purity, concentration, and stability in accordance with international metrological standards for reference materials. The work is to be performed at a facility located in Denver, Colorado, with a strict submission deadline of August 7, 2026, and is issued under a subcontract arrangement by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services. The North American Industry Classification System code 325412 confirms the manufacturing focus on pharmaceutical preparations, emphasizing the technical and regulatory rigor expected from the vendor to meet federal standards for reference standards used in veterinary drug testing and compliance monitoring.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 2 days
View Details
NAICS: 325414
New
Federal
Custom Multi-Component Veterinary Drug Reference Standards (Sulfonamides)The contract involves the manufacture of two certified lots of multi-component sulfonamide reference standards for veterinary drug applications, each consisting of five 1mL ampules with precisely defined concentration ratios aligned to government-specified tables. The materials must be produced to meet stringent quality and stability requirements, including a minimum shelf life of 12 months at the time of shipment, ensuring long-term usability for regulatory and testing purposes. The standards are designated as ICV and CCV, indicating their use as independent calibration and control verification materials critical to analytical validation and compliance. The work is being procured by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with performance expected to occur in Denver, Colorado, and classified under NAICS code 325414 for pharmaceutical and botanical product manufacturing. Submission of proposals is due by August 7, 2026, and the contract is structured as a subcontract, suggesting it may follow an overarching government agreement. All output must adhere to exacting specifications to support federal laboratory and inspection protocols, with no flexibility permitted in composition, packaging, or stability validation.
Biological Product (except Diagnostic) Manufacturing

POSTED

1 day ago

DEADLINE

in 2 days
View Details
NAICS: 325412
New
Federal
Custom Multi-Component Veterinary Drug Reference Standards (Macrolides)The contract involves the production of ISO 17034-certified reference standards for macrolide antibiotics, specifically including Virginiamycin M1, to be delivered in two certified lots designated as ICV and CCV. Each lot will consist of five 1mL glass ampules, prepared under strict quality control to ensure purity, stability, and consistency suitable for use in LC-MS method calibration within veterinary drug testing. Full traceability of materials, processes, and analytical data is required, with each ampule accompanied by a detailed Certificate of Analysis that verifies identity, concentration, homogeneity, and stability under specified conditions. The standards must comply with international metrological requirements to support reliable analytical results in regulatory and diagnostic labs. The work is solicited as a subcontract under the Department of Health and Human Services, specifically managed by the FDA Office of Acquisition and Grant Services, with performance based in Denver, Colorado, 80225. The solicitation was posted on August 4, 2026, and responses are due by August 7, 2026, indicating a tight turnaround for technical proposal submission. The NAICS code 325412 classifies this as pharmaceutical and medicine manufacturing, underscoring the need for specialized expertise in reference material production. Deliverables must meet the highest regulatory benchmarks for certification, ensuring that the reference materials are fit for use in compliance testing, quality assurance, and method validation across veterinary drug monitoring programs.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in 2 days
View Details
NAICS: 325414
New
Federal
Custom Multi-Component Veterinary Drug Reference Standards (NSAIDs)The contract entails the manufacture and delivery of ISO 17034-certified analytical reference standards specifically for nonsteroidal anti-inflammatory drugs (NSAIDs) to support veterinary drug residue testing. Two certified lots—intermediate control verification (ICV) and candidate control verification (CCV)—will be produced, each containing five 1mL glass ampules sealed for stability and purity. The reference standards are to be dissolved in LC-MS grade solvents to ensure compatibility with high-performance liquid chromatography and mass spectrometry workflows. All materials must meet rigorous certification standards to guarantee accuracy, traceability, and consistency in quantitative analytical applications. The work is required to be completed under a subcontract with a response deadline of August 7, 2026, and the place of performance is designated as Denver, Colorado, with a zip code of 80225. The contracting entity is the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, operating under NAICS code 325414, which corresponds to pharmaceutical preparation manufacturing. The deliverables are critical for laboratory quality control and regulatory compliance in animal health testing, requiring strict adherence to certification protocols and documentation without compromising sample integrity or analytical validity.
Biological Product (except Diagnostic) Manufacturing

POSTED

1 day ago

DEADLINE

in 2 days
View Details
NAICS: 81121
New
Federal
Allentown Caging Company Individual Ventilated Cage (IVC) rack service/repairs for 50 existing supporting caging equipment supply and exhaust blower motor units with advanced technological features
Solicitation # 75F40126Q135704
The FDA is seeking service repairs for 50 existing Allentown NexGen Ecoflo individual ventilated cage (IVC) rack blower supply and exhaust motor units at its White Oak Campus in Silver Spring, Maryland, under solicitation number 75F40126Q135704. Originally posted as a small business set-aside under NAICS code 811210 with a $34 million size standard, the requirement received no responses and has since been reissued as full and open competition without any set-aside. The work involves one-time comprehensive diagnostics, OEM-level mechanical repairs, firmware updates, airflow calibration, and certified safety validation of all 50 units to meet BSL-1/2 standards for animal housing. All services must be performed on-site within 90 days of contract award, beginning on or around September 1, 2026. Contractors must use only factory-original parts and OEM-authorized tools and software, and must submit a Letter of Commitment verifying technician certification and direct access to proprietary diagnostics. Technical proposals must be submitted via email by 9:00 a.m. Central Time on August 3, 2026, and must exclude macro-enabled or executable files. Proposals must include an Accessibility Conformance Report using the VPAT template to demonstrate compliance with Section 508 standards for all information and communication technology deliverables, alongside detailed service reports for each unit, including technician names, labor hours, and parts replaced. The contract requires full compliance with the Buy American Act, adherence to the Service Contract Act exemption provisions, and submission of a valid Unique Entity ID. Payment must be processed exclusively through the Treasury’s Invoice Processing Platform, with no allowance for alternative systems like WAWF. The Contracting Officer, Suzanne Martella, will evaluate proposals for responsiveness and technical acceptability under a firm-fixed-price structure, with award expected to be made on a Lowest Price Technically Acceptable basis. Any failure to meet specifications, including non-compliance with accessibility, parts authenticity, or documentation requirements, will result in rejection or remediation at the contractor’s expense. There are no contract options, no separate invoicing for ancillary costs, and no federal holiday work permitted.

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 236220
New
Federal
IRV Exhaust and Vacuum Pump Replacement
Solicitation # 75F40126R00049
The U.S. Food and Drug Administration’s Office of Acquisitions and Grants Services is soliciting bids for the IRV Lab Exhaust and Vacuum Pump Replacement Project at the Pacific Southwest Laboratory in Irvine, California, under solicitation number 75F40126R00049. This is a full and open competition requiring contractors to supply all labor, materials, equipment, supervision, permits, testing, commissioning, and related services necessary to remove the existing laboratory vacuum pump system and install a new exhaust system. The scope includes full integration with the Building Automation System, testing and balancing, commissioning, training, and complete project closeout. A mandatory site visit is scheduled for Wednesday, July 22, 2026, at 8:30 a.m. Pacific Time, and attendance is non-negotiable—proposals from offerors who fail to attend will not be considered. Registration for the site visit must be completed by 12:00 p.m. Pacific Time on Monday, July 20, 2026, with each company limited to three representatives who must present valid government-issued photo IDs and comply with FDA security protocols. All offerors must maintain an active registration in SAM.gov throughout the proposal submission, evaluation, and award phases. The solicitation references multiple attachments detailing the statement of work, technical specifications for Room 2309 exhaust, design documents, pricing schedules, security clearance requirements, past performance questionnaires, and quality assurance templates. The NAICS code for this procurement is 236220, indicating construction of commercial buildings. Proposals are due by 4:00 p.m. Pacific Time on Friday, August 14, 2026. The contracting office is located in Rockville, Maryland, with primary and secondary points of contact listed for inquiries. No set-aside applies, and the estimated contract value is not disclosed.
Commercial and Institutional Building Construction

POSTED

1 day ago

DEADLINE

in 15 days
View Details